NKF Spring Clinical Meetings 2025
NKF Spring Clinical Meetings 2025
Advertisement
Jeffrey Perl, MDNKF Spring Clinical Meetings 2025 | April 22, 2025
Joel Topf spoke with Lazarus Award winner Jeffrey Perl at the National Kidney Foundation Spring Clinical Meetings 2025.
View More
Connie Rhee, MDNKF Spring Clinical Meetings 2025 | April 21, 2025
Joel Topf spoke with Connie Rhee at SCM25 about her study on cognitive function with dialysis vs conservative CKD management.
Bradley Marder, MDNKF Spring Clinical Meetings 2025 | April 18, 2025
Joel Topf spoke with Bradley Marder of Amgen about gout studies at the NKF Spring Clinical Meetings 2025.
Victoria SochaNKF Spring Clinical Meetings 2025 | April 18, 2025
A survey sought insight on nephrologists' practices and perceptions about reproductive care for women with kidney disease.
Jayme Locke, MD, MPHNKF Spring Clinical Meetings 2025 | April 17, 2025
Joel Topf spoke to Excellence in Transplantation Award winner Jayme Locke at the National Kidney Foundation SCM25.
Victoria SochaNKF Spring Clinical Meetings 2025 | April 17, 2025
A study examined the effects of SGLT2i on eGFR slope in patients with autosomal dominant polycystic kidney disease.
Victoria SochaNKF Spring Clinical Meetings 2025 | April 16, 2025
Researchers at SCM25 presented interim results of the SPARTAN trial of sparsentan as a treatment for patients with IgAN.
Victoria SochaNKF Spring Clinical Meetings 2025 | April 15, 2025
One-year results of the AFFINITY trial of atrasentan to treat proteinuria among patients with IgAN were presented at SCM25.
Charlotte RobinsonNKF Spring Clinical Meetings 2025 | April 17, 2025
The National Kidney Foundation (NKF) announced the Spring Clinical Meetings 2025 (SCM25) Outstanding Poster honorees.
Victoria SochaNKF Spring Clinical Meetings 2025 | April 14, 2025
Researchers presented results of an interim analysis of a study of finerenone among patients with CKD and type 2 diabetes.
Charlotte RobinsonNKF Spring Clinical Meetings 2025 | April 13, 2025
Researchers shared baseline characteristics of patients in the phase 3 VISIONARY trial of sibeprenlimab for IgA nephropathy.
Victoria SochaNKF Spring Clinical Meetings 2025 | April 12, 2025
Researchers assessed the burden of cardiovascular-kidney-metabolic (CKM) syndrome using NHANES 2001-2020 data.
Victoria SochaNKF Spring Clinical Meetings 2025 | April 14, 2025
Research examined outcomes associated with blood volume monitoring for patients on hemodialysis and hospitalized with HF.
Charlotte RobinsonNKF Spring Clinical Meetings 2025 | April 11, 2025
Research compared the effects of sparsentan and irbesartan on proteinuria remission in focal segmental glomerulosclerosis.
Charlotte RobinsonNKF Spring Clinical Meetings 2025 | April 10, 2025
A study compared kidney stone formation with the use of chlorthalidone vs hydrochlorothiazide for hypertension.
Victoria SochaNKF Spring Clinical Meetings 2025 | April 7, 2025
Research explored kidney outcomes among young patients receiving glucagon-like peptide-1 receptor agonists (GLP-1 RAs).
Victoria SochaNKF Spring Clinical Meetings 2025 | April 7, 2025
A study compared the impact of conservative management of CKD vs transition to dialysis on risk for cognitive dysfunction.
Charlotte RobinsonNKF Spring Clinical Meetings 2025 | April 14, 2025
Researchers assessed how prescription rates of SGLT2i were affected when DKD risk was predicted by a KidneyIntelX test.
Charlotte RobinsonNKF Spring Clinical Meetings 2025 | April 14, 2025
Research examined the efficacy and safety of lumasiran for primary hyperoxaluria type 1 in infants and toddlers.
Charlotte RobinsonNKF Spring Clinical Meetings 2025 | April 14, 2025
Dosing calculations for carboplatin made using Cockcroft-Gault creatinine clearance may result in excess dosing.
Advertisement
Advertisement
Latest News

April 22, 2025